Assessment of bovine herpesvirus 4 based vector in chicken
- PMID: 18243344
- DOI: 10.1016/j.jviromet.2007.12.006
Assessment of bovine herpesvirus 4 based vector in chicken
Abstract
The biological characteristics of BoHV-4 make it a good candidate as a gene delivery vector for vaccination purposes. These characteristics include little or no pathogenicity, unlikely oncogenicity, the ability to accommodate large amounts of foreign genetic material, the ability to infect several cell types from different animal species, such as sheep, goats, swine, cats, dogs, rabbits, mink, horses, turkeys, ferrets, monkeys, hamsters, rats, mice, and chickens. In this report, the feasibility to use BoHV-4 based vector in chicken was investigated. Although BoHV-4 was able to replicate, leading to a cytopathic effect in a chicken cell line and infect the chorion allantoic membrane of embryonated eggs, however it was not pathogenic even when a large dose of virus was injected into the chicken. An immune response could be produced against heterologous antigen delivered by a recombinant BoHV-4. These data suggest the feasibility of using BoHV-4 based vector for vaccination purposes in chickens.
Similar articles
-
Swine adipose stromal cells loaded with recombinant bovine herpesvirus 4 virions expressing a foreign antigen induce potent humoral immune responses in pigs.Vaccine. 2011 Jan 29;29(5):867-72. doi: 10.1016/j.vaccine.2010.11.048. Epub 2010 Nov 27. Vaccine. 2011. PMID: 21115049
-
Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model.Clin Vaccine Immunol. 2006 Nov;13(11):1246-54. doi: 10.1128/CVI.00200-06. Epub 2006 Aug 23. Clin Vaccine Immunol. 2006. PMID: 16928886 Free PMC article.
-
Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen.Vaccine. 2011 Apr 5;29(16):3074-82. doi: 10.1016/j.vaccine.2011.01.075. Epub 2011 Feb 12. Vaccine. 2011. PMID: 21320537
-
Development and registration of recombinant veterinary vaccines. The example of the canarypox vector platform.Vaccine. 2007 Jul 26;25(30):5606-12. doi: 10.1016/j.vaccine.2006.11.066. Epub 2006 Dec 8. Vaccine. 2007. PMID: 17227690 Review.
-
Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.Semin Cancer Biol. 2008 Dec;18(6):409-15. doi: 10.1016/j.semcancer.2008.09.001. Epub 2008 Sep 30. Semin Cancer Biol. 2008. PMID: 18938248 Review.
Cited by
-
Retinal transduction profiles by high-capacity viral vectors.Gene Ther. 2014 Oct;21(10):855-65. doi: 10.1038/gt.2014.57. Epub 2014 Jul 3. Gene Ther. 2014. PMID: 24989814 Free PMC article.
-
Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease.Front Immunol. 2023 Jul 6;14:1197649. doi: 10.3389/fimmu.2023.1197649. eCollection 2023. Front Immunol. 2023. PMID: 37483612 Free PMC article.
-
Generation and characterization of the first immortalized alpaca cell line suitable for diagnostic and immunization studies.PLoS One. 2014 Aug 20;9(8):e105643. doi: 10.1371/journal.pone.0105643. eCollection 2014. PLoS One. 2014. PMID: 25140515 Free PMC article.
-
Immunization With Bovine Herpesvirus-4-Based Vector Delivering PPRV-H Protein Protects Sheep From PPRV Challenge.Front Immunol. 2021 Sep 14;12:705539. doi: 10.3389/fimmu.2021.705539. eCollection 2021. Front Immunol. 2021. PMID: 34594325 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous